SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported financial results and business highlights for the third quarter ended September ...
WORCESTER, Mass., March 29, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in ...
Bio-Rad Laboratories stock (NYSE: BIO), a life science research and clinical diagnostic products company, has seen a 48% fall this year, significantly underperforming the broader S&P500 index, down 24 ...
Good morning and welcome to the Passage Bio Third Quarter 2022 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please ...
BOSTON--(BUSINESS WIRE)--#BIO2022--BDO’s BioProcess Technology Group (BPTG), the world leader in providing strategic, technical, regulatory, and business consulting services to the biopharmaceutical ...
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported financial results and business highlights for the fourth quarter and full year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback